Ophthalmic Dosage Forms – Page 2

Dropper Compatibility Failure at stability pull: FDA-ready investigation report and batch disposition

Recognizing the symptoms of dropper compatibility failure early in the manufacturing or testing phase can significantly mitigate risks. Typical signals might include:Click to read the full article.

Dropper Compatibility Failure during aseptic filling: sampling, filtration, and EM controls

Dropper compatibility failures can manifest through various symptoms that signal potential issues during the aseptic filling process. Key observations may include:Click to read the full article.

Ccit Failure after packaging change: how to avoid repeat 483 observations

The initial step in addressing a CCIT failure is recognizing the symptoms or signals that indicate a deviation has occurred. These may manifest as:Click to read the full article.

Dropper Compatibility Failure during aseptic filling: FDA-ready investigation report and batch disposition

Identifying symptoms that indicate a dropper compatibility failure is the first step in an effective investigation. Common signs include:Click to read the full article.

Ph Drift in eye drop manufacturing: packaging integrity and CCIT justification

Identifying the symptoms associated with pH drift is critical in early detection and remediation. Common signals include:Click to read the full article.

Ccit Failure during sterile filtration: risk assessment for sterility assurance

Identifying symptoms or signals of CCIT failure during sterile filtration is crucial for prompt mitigation. Key indicators include:Click to read the full article.

Fill Volume Variability during method transfer: sampling, filtration, and EM controls

The first step in addressing fill volume variability is identifying the symptoms or signals indicative of a problem. These can include:Click to read the full article.

E&L Failure after packaging change: packaging integrity and CCIT justification

When E&L failures occur after a packaging change, certain symptoms or signals may be observed. These can manifest in various ways, including:Click to read the full article.

Ph Drift during method transfer: FDA-ready investigation report and batch disposition

Recognizing the initial symptoms of pH drift during method transfer is crucial for timely intervention. Symptoms may include:Click to read the full article.

E&L Failure at stability pull: sampling, filtration, and EM controls

Investigating E&L Failures During Stability Pulls: A Practical Guide In pharmaceutical manufacturing, especially when dealing with ophthalmic dosage forms, extracting the appropriate product for stability pulls is crucial to ensure…

Pet Failure during method transfer: FDA-ready investigation report and batch disposition

Understanding the symptoms observed during the incident is paramount. In recent occurrences of pet failure, the following were noted:Click to read the full article.

Ccit Failure during method transfer: FDA-ready investigation report and batch disposition

CCIT failures can manifest in various ways, indicating potential issues in method transfer or laboratory processes. Key symptoms to monitor include:Click to read the full article.